Customs Rules on Origin of Biomedix IV Drip Products
Published Date: 5/23/2025
Notice
Summary
U.S. Customs and Border Protection has made a final call on where the Biomedix Selec-3 Multiple Drop IV product is made. Depending on the situation, some versions are considered foreign-made, while others are made in the U.S. This decision helps companies know the rules for importing and selling these products, which could affect costs and timing.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Final Origin Ruling for Selec-3 IV
If you import or sell the Biomedix Selec-3 Multiple Drop IV product, U.S. Customs and Border Protection ruled that in 2 of 5 scenarios the product is foreign-made under Title III of the Trade Agreements Act of 1979, and in 3 scenarios the last substantial transformation occurs in the United States. This final determination could affect how the product is imported, labeled, or sold and could change costs and timing for your business.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in